http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2834637-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 2002-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67cc2fb92cb157f7c88ee911958f6d56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610c43973e61b5702d3b21d15133f58f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f4ea21372768ddc05147231d8ab6810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_675b081dcf6087e8cd4d0d3c4402e1ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d272da8e888a9cd6c19317bfa59a75e4
publicationDate 2003-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2834637-A1
titleOfInvention USE OF A NEW CLASS OF MEDICAMENTS FOR THE TREATMENT OF PARASITIC DISEASES
abstract The invention relates to the use of at least one benzodiazepine peripheral receptor ligand molecule (PBR) for the manufacture of medicaments for the treatment of parasitic diseases.
priorityDate 2002-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0151922-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5182387-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4046890-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3393
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1345
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449434161
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53356674
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412828509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563811
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505256

Total number of triples: 51.